1. Home
  2. CERS vs BDMD Comparison

CERS vs BDMD Comparison

Compare CERS & BDMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERS
  • BDMD
  • Stock Information
  • Founded
  • CERS 1991
  • BDMD 2012
  • Country
  • CERS United States
  • BDMD China
  • Employees
  • CERS N/A
  • BDMD N/A
  • Industry
  • CERS EDP Services
  • BDMD
  • Sector
  • CERS Technology
  • BDMD
  • Exchange
  • CERS Nasdaq
  • BDMD NYSE
  • Market Cap
  • CERS 277.2M
  • BDMD 262.8M
  • IPO Year
  • CERS 1997
  • BDMD N/A
  • Fundamental
  • Price
  • CERS $1.39
  • BDMD $2.04
  • Analyst Decision
  • CERS Strong Buy
  • BDMD
  • Analyst Count
  • CERS 2
  • BDMD 0
  • Target Price
  • CERS $3.50
  • BDMD N/A
  • AVG Volume (30 Days)
  • CERS 1.1M
  • BDMD 221.3K
  • Earning Date
  • CERS 08-05-2025
  • BDMD 01-01-0001
  • Dividend Yield
  • CERS N/A
  • BDMD N/A
  • EPS Growth
  • CERS N/A
  • BDMD 18.86
  • EPS
  • CERS N/A
  • BDMD 0.49
  • Revenue
  • CERS $185,144,000.00
  • BDMD $37,037,108.00
  • Revenue This Year
  • CERS $20.97
  • BDMD N/A
  • Revenue Next Year
  • CERS $15.55
  • BDMD N/A
  • P/E Ratio
  • CERS N/A
  • BDMD $4.41
  • Revenue Growth
  • CERS 13.06
  • BDMD 17.73
  • 52 Week Low
  • CERS $1.12
  • BDMD $1.05
  • 52 Week High
  • CERS $2.54
  • BDMD $12.50
  • Technical
  • Relative Strength Index (RSI)
  • CERS 48.50
  • BDMD N/A
  • Support Level
  • CERS $1.35
  • BDMD N/A
  • Resistance Level
  • CERS $1.47
  • BDMD N/A
  • Average True Range (ATR)
  • CERS 0.07
  • BDMD 0.00
  • MACD
  • CERS -0.01
  • BDMD 0.00
  • Stochastic Oscillator
  • CERS 22.73
  • BDMD 0.00

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

About BDMD BAIRD MEDICAL INVESTMENT HLDGS LTD

Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.

Share on Social Networks: